Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 701-27-9 Chemical Structure| 701-27-9

Structure of 701-27-9

Chemical Structure| 701-27-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Fuchs, Kamila ; Janek, Tomasz ; Karpl, Mateusz ; Władyczyn, Anna ; Ejfler, Jolanta ; John, Łukasz

Abstract: This work introduces a novel class of hybrid antimicrobial agents by integrating sulfone and sulfonamide functionalities with polyhedral oligomeric silsesquioxanes (POSSs). By employing efficient synthetic protocols, we have successfully prepared both sulfone (ethylvinylsulfone-POSS and phenylethylsulfone-POSS) and sulfonamide (benzenesulfonamide-POSS, p-toluenesulfonamide-POSS, 3-fluorobenzenesulfonamide-POSS, and 2-naphthalenesulfonamide-POSS) derivatives with high yields (73−90%). All derivatives were examined using Fourier transform infrared spectroscopy, multinuclear (1H, 13C, 13F, and 29Si) NMR spectroscopy, MALDI-ToF MS spectrometry, and elemental analysis. Additionally, the crystal structure of the p-toluenesulfonamide-POSS hybrid was revealed. The unique cage-like POSS structure not only imparts enhanced thermal and chemical stability, a common feature of silsesquioxane-based hybrids, but also boosts the lipophilic character of these compounds, thereby facilitating their interaction with microbial membranes. This interaction, likely resulting in membrane disruption and cell lysis, translates into potent antimicrobial activity (against Escherichia coli, Pseudomonas aeruginosa, Enterococcus hirae, Staphylococcus aureus, and Candida albicans)—especially against Gram-positive bacteria—at remarkably low minimum inhibitory concentrations in the range from 125 to 3000 μM. In turn, E. hirae and S. aureus were more susceptible compared to Gram-negative bacteria and C. albicans. The strategic incorporation of POSSs into these sulfur-based moieties represents a significant breakthrough, opening new avenues for the development of advanced antimicrobial coatings and therapeutic agents in the fight against antibiotic resistance.

Purchased from AmBeed:

Alternative Products

Product Details of [ 701-27-9 ]

CAS No. :701-27-9
Formula : C6H4ClFO2S
M.W : 194.61
SMILES Code : O=S(C1=CC=CC(F)=C1)(Cl)=O
MDL No. :MFCD00042286
InChI Key :OKYSUJVCDXZGKE-UHFFFAOYSA-N
Pubchem ID :2734258

Safety of [ 701-27-9 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H314
Precautionary Statements:P280-P305+P351+P338-P310
Class:8
UN#:3265
Packing Group:

Computational Chemistry of [ 701-27-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 3.0
Num. H-bond donors 0.0
Molar Refractivity 39.48
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

42.52 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.66
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.04
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.25
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.95
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.77
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.13

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.67
Solubility 0.417 mg/ml ; 0.00214 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.56
Solubility 0.535 mg/ml ; 0.00275 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.22
Solubility 0.117 mg/ml ; 0.000601 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.04 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.89

Application In Synthesis of [ 701-27-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 701-27-9 ]

[ 701-27-9 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 701-27-9 ]
  • [ 33084-49-0 ]
  • 3-fluoro-N-(4-bromo-3-methyl-5-isoxazolyl)benzenesulfonamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
88% EXAMPLE 21 3-Fluoro-N-(4-bromo-3-methyl-5-isoxazolyl)benzenesulfonamide 3-Fluoro-N-(4-bromo-3-methyl-5-isoxazolyl) benzenesulfonamide was prepared from <strong>[33084-49-0]5-amino-4-bromo-3-methylisoxazole</strong> and 3-fluorobenzenesulfonyl chloride according to the procedures described in Example 1b. The crude product was purified by recrystallization from ethyl acetate/hexanes to give a light yellow solid, m.p. 125-128 C., yield 88%.
88% EXAMPLE 61 3-Fluoro-N-(4-bromo-3-methyl-5-isoxazolyl)benzenesulfonamide 3-Fluoro-N-(4-bromo-3-methyl-5-isoxazolyl)benzenesulfonamide was prepared from <strong>[33084-49-0]5-amino-4-bromo-3-methylisoxazole</strong> and 3-fluorobenzenesulfonyl chloride according to the procedures described in Example 40b. The crude product was purified by recrystallization from ethyl acetate/hexanes to give a light yellow solid, m.p. 125-128 C., yield 88%.
  • 2
  • [ 701-27-9 ]
  • [ 369-26-6 ]
  • [ 1422828-32-7 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 701-27-9 ]

Fluorinated Building Blocks

Chemical Structure| 349-88-2

A947771 [349-88-2]

4-Fluorobenzene-1-sulfonyl chloride

Similarity: 0.98

Chemical Structure| 210532-25-5

A462045 [210532-25-5]

3,5-Difluorobenzene-1-sulfonyl chloride

Similarity: 0.96

Chemical Structure| 2905-21-7

A266144 [2905-21-7]

2-Fluorobenzene-1-sulfonyl chloride

Similarity: 0.91

Chemical Structure| 351003-43-5

A220276 [351003-43-5]

3,4,5-Trifluorobenzene-1-sulfonyl chloride

Similarity: 0.90

Chemical Structure| 26120-86-5

A642197 [26120-86-5]

2,5-Difluorobenzene-1-sulfonyl chloride

Similarity: 0.90

Aryls

Chemical Structure| 349-88-2

A947771 [349-88-2]

4-Fluorobenzene-1-sulfonyl chloride

Similarity: 0.98

Chemical Structure| 210532-25-5

A462045 [210532-25-5]

3,5-Difluorobenzene-1-sulfonyl chloride

Similarity: 0.96

Chemical Structure| 2905-21-7

A266144 [2905-21-7]

2-Fluorobenzene-1-sulfonyl chloride

Similarity: 0.91

Chemical Structure| 351003-43-5

A220276 [351003-43-5]

3,4,5-Trifluorobenzene-1-sulfonyl chloride

Similarity: 0.90

Chemical Structure| 26120-86-5

A642197 [26120-86-5]

2,5-Difluorobenzene-1-sulfonyl chloride

Similarity: 0.90

Sulfonyl Chlorides

Chemical Structure| 349-88-2

A947771 [349-88-2]

4-Fluorobenzene-1-sulfonyl chloride

Similarity: 0.98

Chemical Structure| 2905-21-7

A266144 [2905-21-7]

2-Fluorobenzene-1-sulfonyl chloride

Similarity: 0.91

Chemical Structure| 351003-43-5

A220276 [351003-43-5]

3,4,5-Trifluorobenzene-1-sulfonyl chloride

Similarity: 0.90

Chemical Structure| 26120-86-5

A642197 [26120-86-5]

2,5-Difluorobenzene-1-sulfonyl chloride

Similarity: 0.90

Chemical Structure| 175278-08-7

A466251 [175278-08-7]

2,3,4-Trifluorobenzene-1-sulfonyl chloride

Similarity: 0.86

Chlorides

Chemical Structure| 349-88-2

A947771 [349-88-2]

4-Fluorobenzene-1-sulfonyl chloride

Similarity: 0.98

Chemical Structure| 210532-25-5

A462045 [210532-25-5]

3,5-Difluorobenzene-1-sulfonyl chloride

Similarity: 0.96

Chemical Structure| 2905-21-7

A266144 [2905-21-7]

2-Fluorobenzene-1-sulfonyl chloride

Similarity: 0.91

Chemical Structure| 351003-43-5

A220276 [351003-43-5]

3,4,5-Trifluorobenzene-1-sulfonyl chloride

Similarity: 0.90

Chemical Structure| 26120-86-5

A642197 [26120-86-5]

2,5-Difluorobenzene-1-sulfonyl chloride

Similarity: 0.90